We have located links that may give you full text access.
A study of discrepancy between laboratory-calculated and weight-based glomerular filtration rate (GFR) as a marker of renal function in a palliative care population.
Journal of Clinical Oncology 2016 October 10
58 Background: Renal function is important in a palliative care population and can impact on frequently-used medications including chemotherapeutic agents, opioids, non-steroidal anti-inflammatory drugs and neuropathic agents. In local practice, estimated glomerular filtration rate (eGFR), calculated on a presumed weight of 70kg, is displayed in laboratory results. However, the weight of palliative patients varies considerably, for example, due to cancer cachexia or malabsorption and a considerable population weigh less than 70kg. Our aim was to assess whether there is a discrepancy between glomerular filtration rate when laboratory-estimated versus weight-based and to explore the potential clinical relevance.
METHODS: Data was retrospectively collated for 50 patients admitted consecutively to a specialist palliative care unit over a 6 month period. Laboratory-derived eGFR was compared to GFR using the Cockroft-Gault equation (CreatClear = Sex*(140-Age)/(SerumCreat))*(Weight/72).
RESULTS: 25 (50%) patients were admitted for end of life care, 19 (38%) for symptom control, 6 (12%) for respite. 36 patients (72%) had weight documented. 45 (90%) patients had bloods taken. 41 patients had an eGFR documented, 7 of whom had an eGFR of less than 60ml/min. 25 patients had a weight-based GFR calculated of whom 10 (40%) had a GFR less than 60ml/min A significant discrepancy was seen between estimated and calculated GFR in 7 of these (accounting for 28%). This was most notable at less than 65kg. 2 patients with a weight of 55kg had a greater than 40ml/min difference in creatinine clearance. 50% of patients with a GFR of less than 60ml/min were on at least one nephrotoxic drug, most frequently pregabalin or ibuprofen. The most frequently-used opioid was oxycodone. No patient had opioids or medications discontinued on the basis of renal function.
CONCLUSIONS: Results show a significant discrepancy between estimated and calculated GFR in a palliative care population which is most pronounced at lower weights. We would recommend, where appropriate, calculating a weight-based GFR on patients, with a review of opioid and nephrotoxic medications when reduced.
METHODS: Data was retrospectively collated for 50 patients admitted consecutively to a specialist palliative care unit over a 6 month period. Laboratory-derived eGFR was compared to GFR using the Cockroft-Gault equation (CreatClear = Sex*(140-Age)/(SerumCreat))*(Weight/72).
RESULTS: 25 (50%) patients were admitted for end of life care, 19 (38%) for symptom control, 6 (12%) for respite. 36 patients (72%) had weight documented. 45 (90%) patients had bloods taken. 41 patients had an eGFR documented, 7 of whom had an eGFR of less than 60ml/min. 25 patients had a weight-based GFR calculated of whom 10 (40%) had a GFR less than 60ml/min A significant discrepancy was seen between estimated and calculated GFR in 7 of these (accounting for 28%). This was most notable at less than 65kg. 2 patients with a weight of 55kg had a greater than 40ml/min difference in creatinine clearance. 50% of patients with a GFR of less than 60ml/min were on at least one nephrotoxic drug, most frequently pregabalin or ibuprofen. The most frequently-used opioid was oxycodone. No patient had opioids or medications discontinued on the basis of renal function.
CONCLUSIONS: Results show a significant discrepancy between estimated and calculated GFR in a palliative care population which is most pronounced at lower weights. We would recommend, where appropriate, calculating a weight-based GFR on patients, with a review of opioid and nephrotoxic medications when reduced.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app